
The new Waqf bill, Manish Sisoda's bail, and waiver for clinical trials
3 Things
00:00
Expedited Drug Approvals in India
This chapter examines a new order from India's drug regulator allowing certain international drugs to enter the Indian market without local clinical trials. It discusses the implications for drug safety and efficacy, the categories of drugs affected, and the factors influencing their success in diverse populations.
Transcript
Play full episode